Ascendis Pharma A/S (ASND) bonds
ASNDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Score 7/30
$271.73−3.66 (-1.33%)
Close on Nov 16, 2026Market cap $16.84BP/E 22.3Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
€384.64M
€0 due within a year
Net debt
-€427.62M
After €812.26M of cash
Implied interest rate
25.24%
FY2025 interest ÷ average debt
Interest coverage
-0.7×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, EUR
Notes and loans outstanding
Individual notes, bonds and loans
Ascendis Pharma A/S's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
See a number that looks wrong?